Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this
Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention
β Scribed by E. W. Gerner; F. L. Meyskens; S. Goldschmid; P. Lance; D. Pelot
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 109 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0939-4451
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND: Numeracy and Adjuvant! are 2 webβbased calculators that are used widely to estimate the prognosis and potential benefit of adjuvant 5βfluorouracil (5βFU)βbased therapy for patients with stage II and III colon cancer. In this study, the authors compared the predicted surv
We developed an interactive and menu-driven computer program to help investigators design and analyze phase II cancer clinical trials with a group sequential method, namely the sequential probability ratio test or the triangular test. Based on the values selected for the parameters of the trial, the